Announcement • Jun 18
Nuwellis, Inc. Announces Chief Executive Officer Changes, Effective June 30, 2026
Nuwellis, Inc. announced the appointment of Mike McCormick as Chief Executive Officer. John Erb, who currently serves as President, CEO, and Chairman of the Board, will transition from his executive leadership role and continue serving as Chairman of the Board. McCormick is a seasoned medical technology executive with more than three decades of leadership experience spanning product development, commercialization, corporate strategy, and value creation. He served as a Board Member and Independent Director of Nuwellis from June 2023 through January 2026. Transition to become effective June 30, 2026. Mr. McCormick, age 65, has provided consulting services to the Company since September 2025, including serving as Chief Commercial Officer under a consulting arrangement. He previously served as a director of the Company from June 2023 to January 2026. Mr. McCormick is a seasoned executive with more than 30 years of experience leading medical device companies and serving on the boards of private and publicly traded life sciences companies. Since 2023, Mr. McCormick has served as President and Chief Executive Officer of CorRen Medical, Inc., a private medical technology company focused on improving the diagnosis and management of peripheral artery disease, and where he will transition to Executive Chairman effective June 30, 2026. From 2010 to 2023, Mr. McCormick served as Chief Executive Officer of Osprey Medical, a commercial-stage medical device company focused on technologies designed to reduce contrast-induced acute kidney injury. From 2003 to 2008, Mr. McCormick served as Chief Executive Officer of Anulex Technologies, Inc., a private company that was subsequently acquired by Boston Scientific. Prior to that, he served as President of Centerpulse Spine-Tech and was involved in its successful acquisition by Zimmer in 2003. Earlier in his career, Mr. McCormick held sales and sales management positions with Boston Scientific Scimed and Baxter Healthcare. Mr. McCormick also serves on various private company boards, including as Executive Chairman of NephroCor Medical, Inc., Chairman of AcQumen Medical, Inc., and as an independent director of Formae, Inc. and Sharp Biomedical, Inc. He previously served as Chairman of OrthoCor Medical, a private company that was acquired in 2019. Mr. McCormick received a Bachelor of Business Administration in Business Management from The University of Texas at Austin.
